COWEN AND COMPANY, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 216 filers reported holding TG THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
COWEN AND COMPANY, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$34,850
-73.0%
82,000
-26.8%
0.00%
-66.7%
Q3 2022$129,000
+69.7%
112,0000.0%0.01%
+71.4%
Q2 2022$76,000
-55.8%
112,000
+775.5%
0.01%
-12.5%
Q3 2021$172,00012,7920.01%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 5,434,783$60,326,0005.25%
RA Capital Management 9,880,323$109,672,0003.33%
BRIDGER MANAGEMENT, LLC 1,907,492$21,173,0001.53%
Eversept Partners, LP 776,323$8,617,1851.52%
Opaleye Management Inc. 579,651$6,434,0001.26%
Sofinnova Investments, Inc. 811,292$9,006,0000.65%
Ikarian Capital, LLC 316,200$3,510,0000.57%
ARMISTICE CAPITAL, LLC 800,000$8,880,0000.51%
683 Capital Management, LLC 398,271$4,421,0000.51%
Frontier Wealth Management LLC 196,750$2,184,0000.35%
View complete list of TG THERAPEUTICS INC shareholders